Clinical Trials
13
Active:8
Completed:5
Trial Phases
2 Phases
Phase 1:4
Phase 2:4
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (8 trials with phase data)• Click on a phase to view related trials
Phase 1
4 (50.0%)Phase 2
4 (50.0%)Effect of Different Pre-seasonal BM32 Dosings on the Induction of a Protective Immune Response
Phase 2
Completed
- Conditions
- Hypersensitivity
- First Posted Date
- 2015-12-31
- Last Posted Date
- 2017-01-19
- Lead Sponsor
- Biomay AG
- Target Recruit Count
- 130
- Registration Number
- NCT02643641
- Locations
- 🇦🇹
Vienna Challenge Chamber, Vienna, Austria
Phase II Study of Grass Pollen Allergy Vaccine BM32
Phase 2
Completed
- Conditions
- Grass Pollen Allergy
- First Posted Date
- 2012-02-27
- Last Posted Date
- 2015-12-18
- Lead Sponsor
- Biomay AG
- Target Recruit Count
- 181
- Registration Number
- NCT01538979
- Locations
- 🇦🇹
Universitätsklinik für Dermatologie und Allergologie, Graz, Austria
🇦🇹Medical University, Vienna, Austria
🇧🇪Allergy Network Ghent University Hospital Ghent, Dept. Otorhiolaryngologie, Ghent, Belgium
Safety and Dose Finding Trial of BM32 in Subjects Suffering From Grass Pollen Allergy
Phase 2
Completed
- Conditions
- Grass Pollen Allergy
- First Posted Date
- 2011-10-03
- Last Posted Date
- 2013-01-14
- Lead Sponsor
- Biomay AG
- Target Recruit Count
- 79
- Registration Number
- NCT01445002
- Locations
- 🇦🇹
Allergy Center Vienna West, Vienna, Austria
Skin Test Study of BM32
Phase 1
Completed
- Conditions
- Hypersensitivity
- First Posted Date
- 2011-05-10
- Last Posted Date
- 2015-12-18
- Lead Sponsor
- Biomay AG
- Target Recruit Count
- 60
- Registration Number
- NCT01350635
- Locations
- 🇦🇹
Medical University, Vienna, Austria
News
No news found